Takeda Pharmaceutical
TAK
#437
Rank
S$69.18 B
Marketcap
S$21.90
Share price
0.35%
Change (1 day)
23.59%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): S$2.58 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are S$29.52 Billion. In 2024 the company made an earning of S$2.83 Billion a decrease over its 2023 earnings that were of S$2.90 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$2.58 B-8.74%
2024 S$2.83 B-2.41%
2023 S$2.90 B-28.14%
2022 S$4.04 B-40.9%
2021 S$6.84 B78.24%
2020 S$3.83 B246.1%
2019 S$1.10 B-48.79%
2018 S$2.16 B-23.64%
2017 S$2.83 B21.7%
2016 S$2.33 B-253.01%
2015 -S$1.53 Billion-159.65%
2014 S$2.55 B13%
2013 S$2.25 B2.46%
2012 S$2.20 B-57.05%
2011 S$5.13 B-10.49%
2010 S$5.73 B-3.99%
2009 S$5.97 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.17 B 1,481.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.86 B 701.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$15.06 B 478.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.47 B 302.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.56 B 344.15%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$29.34 B 1,026.95%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$11.84 B 355.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-S$1.01 Billion-138.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
S$1.16 B-55.15%๐Ÿ‡ฎ๐Ÿ‡ณ India